The North America cell expansion market is expected to reach US$ 14,697.41 Mn in 2027 from US$ 4,522.07 Mn in 2019. The market is estimated to grow with a CAGR of 15.9% from 2019-2027.
The growth in North America is characterized by characterized by increasing prevalence of cancer across the region, new product launches and increasing inclination of patients towards regenerative and personalized medicines. Also, growing R&D expenditure for cancer research are likely to have a positive impact on the growth of the market in the coming years. But, risk of contamination associated with the cell expansion process is likely to hinder the growth of the Cell Expansion market in the future years.
Regenerative medicine has the potential to replace or heal tissues as well as organs damaged by age, disease, or trauma, as well as to normalize congenital defects. Over the last quarter of a century, there has been an emergence of a tissue engineering industry, one that has now evolved into the broader area of regenerative medicine. Regenerative medicine is defined as a rapidly growing interdisciplinary field that involves engineering sciences to develop clinical therapies intended for maintenance, repair, replacement and enhancement of biological function. Cell expansion is a crucial and invariable part of regenerative medicine. On the bases of study and investigation, desired regeneration techniques are used to develop the tissue which involves cell expansion procedures. It helps to understand how to treat injuries and diseases from broken bones to neurodegenerative diseases. Thus, the rise in the adoption of regenerative medicines is expected to foster the demand for cell expansion technique thereby driving the market growth.
In 2019, US accounted the largest market share in the North America cell expansion market, and it is also expected to grow at a faster pace over the forecast period. US is an economically advanced country and the country has presence of various players that are well established in the biotechnology market. The companies are engaged in the research and development activities that are enabling them to develop latest cell therapies and personalized medicines for various diseases. Moreover, the increasing awareness about new therapies in the country is also responsible to stimulate the market growth.
NORTH AMERICA CELL EXPANSION – MARKET SEGMENTATION
By Modality
By Modality
By Application
By End User
By Geography
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 4,522.07 Million |
| Market Size by 2027 | US$ 14,697.41 Million |
| CAGR (2019 - 2027) | 15.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Cell Expansion Market is valued at US$ 4,522.07 Million in 2019, it is projected to reach US$ 14,697.41 Million by 2027.
As per our report North America Cell Expansion Market, the market size is valued at US$ 4,522.07 Million in 2019, projecting it to reach US$ 14,697.41 Million by 2027. This translates to a CAGR of approximately 15.9% during the forecast period.
The North America Cell Expansion Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Cell Expansion Market report:
The North America Cell Expansion Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Cell Expansion Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Cell Expansion Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)